Literature DB >> 7537817

Selective regional vasoconstriction underlying pressor effects of galanin in anaesthetized possums compared with cats.

G P Courtice1, J R Hales, E K Potter.   

Abstract

1. Intravenous administration of porcine galanin (5 nmol kg-1) caused a rise in mean blood pressure in the brush-tailed possum, Trichosurus vulpecula, from 58 +/- 1.6 to 106 +/- 1.6 mmHg. This effect is in contrast to the cat, in which no significant change in blood pressure was recorded in response to galanin (88 +/- 2.3 vs. 86 +/- 2.4 mmHg). 2. Cardiac output and regional blood flow distribution were assessed by distribution of radioactive microspheres in four anaesthetized possums and four cats, before and after administration of galanin. 3. Cardiac output was 289.8 +/- 14.0 ml min-1 in the cat and 189.9 +/- 25.5 ml min-1 in the possum. Galanin administration did not significantly change cardiac output in either species. 4. In the possum, galanin administration caused large increases in resistance to flow in the spleen, gut, adrenal glands, kidney, skin and carcass. The largest increase was in the kidneys, where renal blood flow fell to 6% of control levels. 5. In the cat, changes in resistance were small. Small increases in resistance to flow in muscle and carcass were offset by small decreases in resistance in the lungs and kidneys. 6. The results suggest that the pressor effect of galanin in the possum is the result of direct vasoconstrictor action in several vascular beds, in contrast to the cat, in which such effects are few and weak.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7537817      PMCID: PMC1155942          DOI: 10.1113/jphysiol.1994.sp020452

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  20 in total

1.  Effects of sympathetic activity and galanin on cardiac vagal action in anaesthetized cats.

Authors:  L G Ulman; E K Potter; D I McCloskey
Journal:  J Physiol       Date:  1992-03       Impact factor: 5.182

2.  Effect of neuropeptide-Y and galanin on autonomic control of heart rate in the toad, Bufo marinus.

Authors:  G P Courtice
Journal:  J Auton Nerv Syst       Date:  1991-05

3.  Standard metabolism, body temperature, and surface areas of Australian marsupials.

Authors:  T J Dawson; A J Hulbert
Journal:  Am J Physiol       Date:  1970-04

4.  Galanin - a novel biologically active peptide from porcine intestine.

Authors:  K Tatemoto; A Rökaeus; H Jörnvall; T J McDonald; V Mutt
Journal:  FEBS Lett       Date:  1983-11-28       Impact factor: 4.124

5.  Different nerve responses in consecutive sections of the arterial system.

Authors:  H Nilsson
Journal:  Acta Physiol Scand       Date:  1984-08

6.  Inhibition of cardiac vagal action by galanin but not neuropeptide Y in the brush-tailed possum Trichosurus vulpecula.

Authors:  G P Courtice; E K Potter; D I McCloskey
Journal:  J Physiol       Date:  1993-02       Impact factor: 5.182

7.  The distribution and colocalization of neuropeptides in perivascular nerves innervating the large arteries and veins of the snake, Elaphe obsoleta.

Authors:  P J Davies; J A Donald
Journal:  Cell Tissue Res       Date:  1992-09       Impact factor: 5.249

8.  Comparison of the inhibitory roles of neuropeptide Y and galanin on cardiac vagal action in the dog.

Authors:  M Moriarty; I L Gibbins; E K Potter; D I McCloskey
Journal:  Neurosci Lett       Date:  1992-05-25       Impact factor: 3.046

9.  Galanin is more common than NPY in vascular sympathetic neurons of the brush-tailed possum.

Authors:  J L Morris; I L Gibbins; S Holmgren
Journal:  Regul Pept       Date:  1992-01-23

10.  Selective constriction of small cutaneous arteries by NPY matches distribution of NPY in sympathetic axons.

Authors:  J L Morris
Journal:  Regul Pept       Date:  1994-01-13
View more
  1 in total

1.  The role of bradykinin in the regulation of blood flow to hindlimb muscle groups of the anaesthetized cat.

Authors:  S M Poucher; S Garcia; R Brooks
Journal:  J Physiol       Date:  1998-07-15       Impact factor: 5.182

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.